Biogen Receives Honorable Mention From Fast Company's World Changing Ideas Awards
May 4, 2021 /3BL Media/ - Biogen received an honorable mention in the Corporate Social Responsibility category of Fast Company’s 2021 World Changing Ideas.
The biotechnology company’s “world changing” idea is Healthy Climate, Healthy Lives, a 20-year, $250-million commitment to go beyond net zero and become fossil fuel free across its operations by 2040 – with an approach designed to advance climate, health and equity. Through this program, Biogen is actively eliminating its combustion of fossil fuels, investing in green chemistry, aligning with suppliers around climate targets, helping employees go fossil-fuel free, and collaborating with global leaders to influence climate policy and improve health outcomes for the world’s most vulnerable.
Healthy Climate, Healthy Lives stood out among more than 4,000 entries from across the globe. Learn more about Biogen’s environmental, social, and governance commitments in its 2020 Year in Review: https://www.biogen.com/en_us/yearinreview.html
About Biogen
At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, commercializes biosimilars of advanced biologics and is focused on advancing research programs in multiple sclerosis and neuroimmunology, Alzheimer’s disease and dementia, neuromuscular disorders, movement disorders, ophthalmology, immunology, neurocognitive disorders, acute neurology and pain.
We routinely post information that may be important to investors on our website at www.biogen.com. Follow us on social media – Twitter, LinkedIn, Facebook, YouTube.
